Proteasome inhibition by Carfilzomib, but not by Bortezomib, induces a specific, proteasome subunit-dependent impairment in cardiac contractility

Mendez, M.; Besse, A.; Besse, L.; Florea, B.I.; Christian, Z.; Overkleeft, H.S.; Driessen, C. (2019)

Article / Letter to editor

• Cardiotoxicity
• Proteasome Inhibitor
• Proteomics

• All authors: Mendez, M.; Besse, A.; Besse, L.; Florea, B.I.; Christian, Z.; Overkleeft, H.S.; Driessen, C.
• Date: 2019-10-31
• Volume: 19
• Issue: 10
• Pages: E119
• DOI: doi:10.1016/j.clml.2019.09.197
• Link: https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(19)31584-8/pdf